eFFECTOR Therapeutics, Inc.(EFTR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EFTR eFFECTOR Therapeutics, Inc.

交易中 07-22 09:47:32 EDT 延时

{"stockData":{"symbol":"EFTR","market":"US","secType":"STK","nameCN":"eFFECTOR Therapeutics, Inc.","latestPrice":0.053,"timestamp":1721656052355,"preClose":0.055,"halted":0,"volume":11637,"delay":15,"floatShares":4582094,"shares":4704409,"eps":-12.424385,"marketStatus":"交易中","marketStatusCode":2,"change":-0.002,"latestTime":"07-22 09:47:32 EDT 延时","open":0.0535,"high":0.055,"low":0.052,"amount":616.0485,"amplitude":0.054545,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-12.424385,"exchange":"PINK","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721678400000},"adr":0,"adjPreClose":0.055,"volumeRatio":1.046184},"requestUrl":"/m/hq/s/EFTR","defaultTab":"news","newsList":[{"id":"2448526971","title":"Effector Therapeutics, Inc.股价重挫13.08% 市值跌14.27万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448526971","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448526971?lang=zh_cn&edition=full","pubTime":"2024-07-02 21:31","pubTimestamp":1719927080,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日21时31分，Effector Therapeutics, Inc.股票出现异动，股价快速跳水13.08%。Effector Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.64%。Effector Therapeutics, Inc.公司简介：eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司，专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407022131209566c7ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407022131209566c7ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EFTR","LENZ"],"gpt_icon":0},{"id":"2446468363","title":"Effector Therapeutics, Inc.盘中异动 急速跳水7.32%报0.287美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446468363","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446468363?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:31","pubTimestamp":1719581467,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时31分，Effector Therapeutics, Inc.股票出现异动，股价急速下跌7.32%。Effector Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Effector Therapeutics, Inc.公司简介：eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司，专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062821310795e38055&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062821310795e38055&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EFTR","LENZ","BK4139"],"gpt_icon":0},{"id":"2446555270","title":"Effector Therapeutics, Inc.盘中异动 股价大涨6.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446555270","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446555270?lang=zh_cn&edition=full","pubTime":"2024-06-27 22:01","pubTimestamp":1719496894,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日22时01分，Effector Therapeutics, Inc.股票出现异动，股价大幅拉升6.32%。Effector Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Geovax Labs, Inc.、Nls Pharmaceutics Ltd.、凯信远达涨幅较大，Geovax Labs, Inc.、Nls Pharmaceutics Ltd.、Kala Bio, Inc.较为活跃，换手率分别为830.92%、218.19%、193.52%，振幅较大的相关个股有Geovax Labs, Inc.、Nls Pharmaceutics Ltd.、Effector Therapeutics Inc C/Wts 31/12/2025 ，振幅分别为99.75%、70.04%、66.67%。Effector Therapeutics, Inc.公司简介：eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司，专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627220134941f1d47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627220134941f1d47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","EFTR","BK4139"],"gpt_icon":0},{"id":"2445727400","title":"Effector Therapeutics, Inc.股价重挫71.80% 市值跌111.43万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445727400","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445727400?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:31","pubTimestamp":1719235915,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时31分，Effector Therapeutics, Inc.股票出现波动，股价快速下跌71.80%。Effector Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。Effector Therapeutics, Inc.公司简介：eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司，专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062421315595d2b54d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062421315595d2b54d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","EFTR"],"gpt_icon":0},{"id":"2443632876","title":"Effector Therapeutics, Inc.盘中异动 股价大涨5.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443632876","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443632876?lang=zh_cn&edition=full","pubTime":"2024-06-14 02:13","pubTimestamp":1718302413,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日02时13分，Effector Therapeutics, Inc.股票出现波动，股价急速上涨5.93%。Effector Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Effector Therapeutics, Inc.公司简介：eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司，专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061402133396814103&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061402133396814103&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EFTR","BK4139","LENZ"],"gpt_icon":0},{"id":"2442842850","title":"Effector Therapeutics, Inc.盘中异动 早盘急速下挫6.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442842850","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442842850?lang=zh_cn&edition=full","pubTime":"2024-06-10 21:40","pubTimestamp":1718026842,"startTime":"0","endTime":"0","summary":"北京时间2024年06月10日21时40分，Effector Therapeutics, Inc.股票出现波动，股价快速下挫6.69%。Effector Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Effector Therapeutics, Inc.公司简介：eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司，专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610214042941ed690&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610214042941ed690&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","EFTR"],"gpt_icon":0},{"id":"2440231845","title":"Effector Therapeutics, Inc.盘中异动 早盘股价大跌5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440231845","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440231845?lang=zh_cn&edition=full","pubTime":"2024-06-04 22:32","pubTimestamp":1717511542,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日22时32分，Effector Therapeutics, Inc.股票出现异动，股价急速跳水5.77%。Effector Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Annexon, Inc.、Cingulate Inc C/Wts 10/12/2026 、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Bio-Path Holdings, Inc.、Fresh2 Group Limited、Annexon, Inc.较为活跃，换手率分别为59.45%、38.82%、34.81%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Annexon, Inc.、Silo Pharma, Inc.，振幅分别为181.00%、35.37%、28.08%。Effector Therapeutics, Inc.公司简介：eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司，专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060422322396811e5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060422322396811e5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EFTR","LENZ","BK4139"],"gpt_icon":0},{"id":"2439056285","title":"Effector Therapeutics, Inc.盘中异动 快速下挫5.14%报1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439056285","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439056285?lang=zh_cn&edition=full","pubTime":"2024-05-30 01:24","pubTimestamp":1717003490,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日01时24分，Effector Therapeutics, Inc.股票出现异动，股价快速下挫5.14%。截至发稿，该股报1.66美元/股，成交量3.4983万股，换手率0.74%，振幅4.00%。Effector Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.85%。Effector Therapeutics, Inc.公司简介：eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司，专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530012450aef25a3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530012450aef25a3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","EFTR","BK4139"],"gpt_icon":0},{"id":"2438727703","title":"Effector Therapeutics, Inc.盘中异动 大幅下跌6.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438727703","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438727703?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:32","pubTimestamp":1716903145,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时32分，Effector Therapeutics, Inc.股票出现波动，股价大幅下跌6.18%。Effector Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.86%。其相关个股中，Insmed Incorporated、Calliditas Therapeutics Ab、Exicure, Inc.涨幅较大，Exicure, Inc.、Nls Pharmaceutics Ltd.、Jaguar Health, Inc.较为活跃，换手率分别为19.00%、7.43%、7.10%，振幅较大的相关个股有Exicure, Inc.、Corcept医疗、Sensei Biotherapeutics, Inc.，振幅分别为20.73%、13.15%、10.20%。Effector Therapeutics, Inc.公司简介：eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司，专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213225956f16f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213225956f16f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EFTR","LENZ"],"gpt_icon":0},{"id":"2437299765","title":"Effector Therapeutics, Inc.盘中异动 快速下挫6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437299765","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437299765?lang=zh_cn&edition=full","pubTime":"2024-05-22 22:19","pubTimestamp":1716387570,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日22时19分，Effector Therapeutics, Inc.股票出现异动，股价快速跳水6.15%。Effector Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Effector Therapeutics, Inc.公司简介：eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司，专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522221930aef11925&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522221930aef11925&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","EFTR"],"gpt_icon":0},{"id":"2434202136","title":"eFFECTOR Therapeutics Inc 报告截至 1 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2434202136","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434202136?lang=zh_cn&edition=full","pubTime":"2024-05-10 06:23","pubTimestamp":1715293425,"startTime":"0","endTime":"0","summary":"   * eFFECTOR Therapeutics Inc   报告，截至1月底的季度调整后每股亏损2.16美元，高于去年同期的每股收益6.00美元。华尔街预期为每股亏损 2.35 美元至 1.98 美元。* eFFECTOR Therapeutics Inc 公布的季度每股收益为亏损 2.16 美元。* 该公司当季亏损 883 万美元。* eFFECTOR Therapeutics Inc 本季度股价下跌了 85.5%，今年迄今为止下跌了 82.2%。5月9日 - 预测变化   * 过去三个月，分析师的平均盈利预期下降了约 13.9%。华尔街对 eFFECTOR Therapeutics Inc 的 12 个月目标价中位数为 11.00 美元。本摘要由 LSEG 5 月 9 日 10:23 p.m. UTC 数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LENZ","EFTR"],"gpt_icon":0},{"id":"2432573975","title":"eFFECTOR Therapeutics Inc    预计每股亏损 2.16 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432573975","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432573975?lang=zh_cn&edition=full","pubTime":"2024-05-03 19:56","pubTimestamp":1714737369,"startTime":"0","endTime":"0","summary":"   * eFFECTOR Therapeutics Inc     预计在5月7日公布截至2024年3月31日的业绩时，季度收入将没有变化(预计)    *    * LSEG 的分析师平均预计 eFFECTOR Therapeutics Inc 每股亏损 2.16 美元。* 在过去三个月中，分析师的平均盈利预期上升了约 24.9%。* 华尔街对 eFFECTOR Therapeutics Inc 的 12 个月目标价中位数为 11.00 美元，高于其最新收盘价 2.16 美元。5月3日 - 本摘要于北京时间 5 月 3 日 11:56 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EFTR","LENZ"],"gpt_icon":0},{"id":"2431586695","title":"Effector Therapeutics, Inc.盘中异动 早盘股价大涨5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431586695","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431586695?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:31","pubTimestamp":1714397490,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时31分，Effector Therapeutics, Inc.股票出现异动，股价快速拉升5.77%。Effector Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Soleno Therapeutics, Inc.、Zyversa Therapeutics, Inc.、Immunitybio, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为401.62%、22.60%、9.66%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Zyversa Therapeutics, Inc.、Calcimedica, Inc.，振幅分别为19.05%、13.83%、10.09%。Effector Therapeutics, Inc.公司简介：eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司，专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429213130861ea157&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429213130861ea157&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EFTR","LENZ"],"gpt_icon":0},{"id":"2430496205","title":"Effector Therapeutics, Inc.盘中异动 早盘股价大涨6.08%报1.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430496205","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430496205?lang=zh_cn&edition=full","pubTime":"2024-04-26 22:06","pubTimestamp":1714140400,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日22时06分，Effector Therapeutics, Inc.股票出现波动，股价急速拉升6.08%。Effector Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Effector Therapeutics, Inc.公司简介：eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司，专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042622064087e8436c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042622064087e8436c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EFTR","BK4139","LENZ"],"gpt_icon":0},{"id":"2428668577","title":"Effector Therapeutics, Inc.盘中异动 早盘大幅跳水5.06%报1.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428668577","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428668577?lang=zh_cn&edition=full","pubTime":"2024-04-19 22:39","pubTimestamp":1713537595,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日22时39分，Effector Therapeutics, Inc.股票出现异动，股价快速下跌5.06%。Effector Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Effector Therapeutics, Inc.公司简介：eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司，专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419223956861e779c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419223956861e779c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","EFTR","BK4139"],"gpt_icon":0},{"id":"2426733829","title":"Effector Therapeutics, Inc.盘中异动 股价大跌6.04%报2.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426733829","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426733829?lang=zh_cn&edition=full","pubTime":"2024-04-12 21:50","pubTimestamp":1712929858,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日21时50分，Effector Therapeutics, Inc.股票出现波动，股价急速下挫6.04%。Effector Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Paxmedica, Inc.、Allarity Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为2117.26%、778.57%、35.91%，振幅较大的相关个股有Paxmedica, Inc.、Allarity Therapeutics, Inc.、Qualigen Therapeutics, Inc.，振幅分别为69.81%、60.95%、17.87%。Effector Therapeutics, Inc.公司简介：eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司，专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041221505979203ad6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041221505979203ad6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EFTR","LENZ","BK4139"],"gpt_icon":0},{"id":"2425099013","title":"Effector Therapeutics, Inc.盘中异动 早盘快速跳水5.15%报2.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425099013","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2425099013?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:31","pubTimestamp":1712583070,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日21时31分，Effector Therapeutics, Inc.股票出现波动，股价快速跳水5.15%。Effector Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。其相关个股中，Longeveron Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Oculis Holding Ag C/Wts 06/03/2028 涨幅较大，Allarity Therapeutics, Inc.、Longeveron Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为493.70%、297.85%、51.62%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Longeveron Inc.、Praxis Precision Medicines, Inc.，振幅分别为6.03%、4.55%、4.46%。Effector Therapeutics, Inc.公司简介：eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司，专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040821311087e7e89f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040821311087e7e89f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EFTR","LENZ","BK4139"],"gpt_icon":0},{"id":"2425654205","title":"Effector Therapeutics, Inc.盘中异动 早盘大幅下挫5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425654205","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2425654205?lang=zh_cn&edition=full","pubTime":"2024-04-05 21:38","pubTimestamp":1712324336,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日21时38分，Effector Therapeutics, Inc.股票出现异动，股价大幅下跌5.07%。Effector Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Effector Therapeutics, Inc.公司简介：eFFECTOR Therapeutics Inc是一家处于临床阶段的生物制药公司，专注于开拓开发一类称为选择性翻译调节抑制剂的新型肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040521385687e7e278&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040521385687e7e278&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","EFTR","BK4139"],"gpt_icon":0},{"id":"2424924293","title":"BUZZ-eFFECTOR Therapeutics 因计划停止开发肺癌疗法而暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2424924293","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2424924293?lang=zh_cn&edition=full","pubTime":"2024-04-04 21:41","pubTimestamp":1712238112,"startTime":"0","endTime":"0","summary":"    4月4日 - ** eFFECTOR Therapeutics   股价下跌78.6%至3.53美元的历史新低 ** 该公司称 ，它将停止开发用于治疗非小细胞肺癌的实验性疗法 tomivosertib** EFTR表示，虽然tomivosertib在中期研究中表现出了一定的活性，但它认为继续开发的道路并不明显。** 该公司称，tomivosertib与默克公司  的抗癌药Keytruda联用时，出现治疗突发不良事件的比例为67%，而安慰剂加Keytruda的比例为37%。** NSCLC是最常见的肺癌形式** 今年以来，股价下跌了约 69.8%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","LENZ","LU0208291251.USD","LU0320765489.SGD","SG9999014567.USD","LU1917777945.USD","SG9999014575.USD","LU2023250504.SGD","SG9999015358.SGD","IE00BSNM7G36.USD","MRK","SG9999013999.USD","BK4585","SG9999014559.SGD","LU0861579265.USD","LU1430594728.SGD","IE00B1BXHZ80.USD","LU0289739699.SGD","LU0965509101.SGD","LU1585245621.USD","LU1974910355.USD","SG9999001440.SGD","LU1291159041.SGD","LU2468319806.SGD","BUZZ","IE0009355771.USD","IE00B2B36J28.USD","LU1066053197.SGD","LU2023250843.SGD","LU1057294990.SGD","LU2106854487.HKD","LU0234572021.USD","LU0238689110.USD","LU0266013472.USD","BK4139","EFTR","BK4559","LU1023059063.AUD","BK4516","IE00BLSP4239.USD","IE00BFTCPJ56.SGD","LU0965509283.SGD","SG9999002232.USD","BK4550","SG9999002224.SGD","IE00BJT1NW94.SGD","SG9999014542.SGD","BK4588","LU0965509010.AUD","LU0070302665.USD"],"gpt_icon":0},{"id":"2422718455","title":"eFFECTOR Therapeutics Inc 报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2422718455","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422718455?lang=zh_cn&edition=full","pubTime":"2024-03-26 05:15","pubTimestamp":1711401308,"startTime":"0","endTime":"0","summary":"   * eFFECTOR Therapeutics Inc   报告，截至12月底的季度调整后每股亏损3.42美元，高于去年同期的每股收益5.50美元。两位分析师对该季度的平均预期是每股亏损 1.65 美元。华尔街预期为每股亏损 3.21 美元至-9 美分。* eFFECTOR Therapeutics Inc 公布的季度每股收益为亏损 3.42 美元。* 该公司当季亏损 913 万美元。* eFFECTOR Therapeutics Inc 的股价本季度上涨了 5.5%。华尔街对 eFFECTOR Therapeutics Inc 的 12 个月目标价中位数为 22.50 美元。本摘要由 LSEG 3 月 25 日 09:15 p.m. UTC 的数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EFTR","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.effector.com","description":"eFFECTOR Therapeutics, Inc.是一家于2020年10月2日在特拉华州注册成立的公司。eFFECTOR是一家临床阶段的生物制药公司，专注于开拓一类被称为选择性翻译调节剂抑制剂(STRIs)的新型肿瘤药物的开发。","exchange":"PINK","name":"eFFECTOR Therapeutics, Inc.","nameEN":"eFFECTOR Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"eFFECTOR Therapeutics, Inc.(EFTR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供eFFECTOR Therapeutics, Inc.(EFTR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"eFFECTOR Therapeutics, Inc.,EFTR,eFFECTOR Therapeutics, Inc.股票,eFFECTOR Therapeutics, Inc.股票老虎,eFFECTOR Therapeutics, Inc.股票老虎国际,eFFECTOR Therapeutics, Inc.行情,eFFECTOR Therapeutics, Inc.股票行情,eFFECTOR Therapeutics, Inc.股价,eFFECTOR Therapeutics, Inc.股市,eFFECTOR Therapeutics, Inc.股票价格,eFFECTOR Therapeutics, Inc.股票交易,eFFECTOR Therapeutics, Inc.股票购买,eFFECTOR Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"eFFECTOR Therapeutics, Inc.(EFTR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供eFFECTOR Therapeutics, Inc.(EFTR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}